Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Prostate/GU 77

77 - Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity? (ID 421)

Session Name
10 - Center for Therapy Excellence YIA Symposium
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Prostate/GU
Presentation Number
77

Previous Eposter
76 - Effects of amino acid co-infusion on increased catecholamine symptoms in metastatic pheochromocytoma patients treated with 177Lu-DOTATATE (ID 420)

Next Eposters
88 - Image-based biomarkers for low-risk NSCLC using texture analysis of F-18-FDG-PET/CT: determination of optimal parameters and their prognostic threshold (ID 819)
91 - Investigation of the Anterior Iliac Spines as an Internal Reference for Tibial Stress Fracture Diagnosis (ID 719)
109 - Performance characteristics and quantitative clinical evaluation of the digital Siemens Biograph Vision PET/CT (ID 19)
115 - PET imaging of [11C](R)(-)NR2B-Me, a novel radioligand for the NR2B subunit of the NMDA receptor, in rhesus macaques (ID 770)
147 - 18F-FDG PET/CT IN LUNG CANCER PATIENTS UNDERGOING IMMUNOTHERAPY: A PRELIMINARY MONOCENTRIC EXPERIENCE (ID 827)
149 - Association of tumor PD-L1 expression and texture features of18F-FDG PET in lung cancer (ID 824)
170 - ECG-gated dynamic myocardial PET with 15O-H2O estimated higher perfusable tissue fraction in the ischemic myocardial lesions after revascularization: compared with conventional non-gated PET (ID 1041)
173 - Impact of attenuation correction on image-derived input functions and cerebral blood flow quantification with simultaneous [15O]-water PET/MRI (ID 877)
188 - Performance of a Dual-Layer Scanner for Hybrid SPECT/CBCT (ID 103)
199 - Validation of [68Ga]-Ga-DOTA-TATE using 68Ga produced by cyclotron (ID 129)